Congenital Heart Disease Clinical Trial
Official title:
Fontan Patients: Comprehensive Evaluation of the Pulmonary Circulation to Identify Pulmonary Vascular Disease and Its Influence on Ventricular Hemodynamics.
In patients with one anatomical or functional ventricular chamber, which encompasses a
spectrum of rare and complex congenital cardiac malformations, a staged surgical approach in
view of an ultimate Fontan operation has become the procedure of choice. Especially in the
earlier era, perioperative mortality was the leading cause of death. However, many patients
have a long and high-quality life, continuously improved by a better understanding of Fontan
hemodynamics and the refinement of the surgical procedures. Nevertheless, the prospect of
eventual failure of the Fontan circulation remains a major concern. More specifically,
evaluation of the pulmonary circulation becomes particularly important as the failing Fontan
circulation has become a common indication for cardiac transplantation. Although essential,
especially in the preoperative setting, a comprehensive evaluation of the pulmonary
circulation remains difficult in this patient population
Our global hypothesis is that the absence of pulsatile pulmonary flow may lead to the
development of pulmonary vascular lesions after the Fontan operation and that - together the
absence of a subpulmonary ventricle for pressure generation - this increasing afterload will
result in systemic ventricular underfilling and will eventually lead to a failing Fontan
circulation.
Background
In patients with one anatomical or functional ventricular chamber, which encompasses a
spectrum of rare and complex congenital cardiac malformations, a staged surgical approach in
view of an ultimate Fontan operation has become the procedure of choice. Especially in the
earlier era, perioperative mortality was the leading cause of death. However, many patients
have a long and high-quality life, continuously improved by a better understanding of Fontan
hemodynamics and the refinement of the surgical procedures. Nevertheless, the prospect of
eventual failure of the Fontan circulation remains a major concern. More specifically,
evaluation of the pulmonary circulation becomes particularly important as the failing Fontan
circulation has become a common indication for cardiac transplantation. Although essential,
especially in the preoperative setting, a comprehensive evaluation of the pulmonary
circulation remains difficult in this patient population.
Different types of Fontan circulation
Atriopulmonary connection
In the atriopulmonary connection, the right atrium is interposed as a valveless contractile
chamber between the systemic venous and pulmonary arterial bed. Although initially believed
to be beneficial, the interposition of such a valveless pulsatile chamber does not
contribute positively to fluid energy. Moreover, pulsation results at the price of higher
upstream pressures, whereas downstream pressures remain unchanged.
Total cavopulmonary shunts
This procedure consists of diverting the superior vena cava return into the pulmonary
arteries and connecting the vena cava inferior to the pulmonary arteries. This action is
achieved either by the construction of a composite conduit made of the sinus venarum and a
prosthetic patch (intracardiac total cavopulmonary connection or lateral tunnel) or by an
extracardiac conduit (extracardiac total cavopulmonary connection).
Our global hypothesis is that the absence of pulsatile pulmonary flow may lead to the
development of pulmonary vascular lesions after the Fontan operation and that - together the
absence of a subpulmonary ventricle for pressure generation - this increasing afterload will
result in systemic ventricular underfilling and will eventually lead to a failing Fontan
circulation.
Fontan attrition
The systemic ventricle
Although preload reduction may lead to inappropriate ventricular hypertrophy, with
concomitant ventricular relaxation problems and a decreased capacity for adaptation to
increased afterload, it is generally accepted that the pulmonary vasculature is more
important than mild ventricular dysfunction in this patient population. Naturally, severe
ventricular dysfunction will affect patient's prognosis.
The pulmonary circulation
The absence of a right ventricular to pulmonary arterial coupling has a profound influence
on systemic venous return and the pulmonary circulation. Several aspects have to be taken
into account when evaluating the pulmonary circulation
1. Systemic venous pressure.
Systemic venous pressures, which are approximately 5 mmHg in healthy controls at rest
and remains unchanged during exercise, are higher in Fontan patients. In Fontan
patients, the absence of a right ventricle for pressure generation, some degree of
congestion is required in order to force transpulmonary flow. However, at rest
pressures above 20 mmHg are rarely seen as such pressures would lead to complications
(oedema, pleural effusions and ascites). Interestingly, pressure change observed during
exercise in normals and Fontan patients is quite similar. In healthy controls, an
increase in mean pulmonary artery pressure from 15 mmHg at rest to 30 mmHg during
exercise. In Fontan patients, mean right atrial pressure increased from 15 mmHg at rest
to 25 mmHg during exercise.
2. Left atrial pressure.
In healthy controls, left atrial pressures shows little variability at rest and is
mainly determined by the atrioventricular valve and ventricular dysfunction. In Fontan
patients, diastolic parameters are more difficult to assess as preload insufficiency
should be considered.8 During exercise, left atrial pressure normally remains stable or
increases somewhat in healthy individuals. However, there are few data available on
left atrial pressures during exercise in Fontan patients.
3. Pulmonary circulation
Although there is still no unequivocal proof, several authors indicated that PVR appears to
be the major determinant of cardiac output in Fontan patients at rest and during exercise. A
low PVR is even more important in these patients as they do not have the possibility for
adapting to a higher afterload, whereas in patients with a subpulmonary ventricle, increased
afterload will be countered by RV hypertrophy. It has been suggested that Fontan patients
having low PVR remain stable for many decades, whereas a high PVR appears to be poor
prognostic factor.
Measurement of PVR and problems in Fontan patients
Most commonly, PVR is measured using the Fick method based on the principle that a known
amount of a specific indicator is added to a volume of fluid. If the concentration before
and after this addition is known, the volume of fluid can be calculated. The Fick method
uses the physiological uptake of oxygen as an indicator. However, this method may be
inaccurate in this patient population. Other techniques, such as the dye dilution technique
or thermodilution technique suffer from their own limitations, such as reduced reliability
in the presence of shunts or valvular regurgitation.
In order to provide a more accurate measurement of PVR, a combined approach of invasive
pressure measurements and velocity-encoded magnetic resonance has become available, and has
proven to be feasible in different patient populations. Cardiac output measured using this
approach has been shown to be accurate and feasible in Fontan patients. Moreover, flow
through to left and right pulmonary artery can be measured separately.
Measurement of PVR and ventricular volumes during exercise
As mentioned earlier, transpulmonary flow in Fontan patients is dependent on the presence of
low PVR and normal behavior of PVR during exercise in order to be able to increase cardiac
output. An increase in PVR during exercise would cause a more pronounced underfilling of the
systemic ventricle with subsequently less increase or even decrease in stroke volume. Both
pressure and flow measurements have been shown feasible in patients with congenital heart
disease at rest and during exercise.
Measurement of PVR and ventricular volumes after vasodilatation Several studies have shown
that drugs affecting the pulmonary vasculature (sildenafil, bosentan, NO) reduce PVR and
increase cardiac output in selected patients. Especially in patients with elevated PVR,
these drugs have the potential to decrease PVR and increase ventricular volumes, cardiac
output and exercise tolerance. Whether these drugs improve outcome remains to be evaluated.
Aims of the study
Feasibility of measuring PVR in Fontan patients using simultaneous acquisition of invasive
pressures and MR flow data.
Effect of Sildenafil 50 mg on PVR, ventricular volume and function at rest
Effect of bicycle stress on PVR, ventricular volume and function
Evaluating the reliability of bicycle stress echocardiography in determining ventricular
volume and function as an indirect parameter reflecting the status of the pulmonary
vasculature
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04992793 -
Paediatric Brain Injury Following Cardiac Interventions
|
||
Recruiting |
NCT05213598 -
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
|
||
Completed |
NCT04136379 -
Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
|
||
Completed |
NCT04814888 -
3D Airway Model for Pediatric Patients
|
||
Recruiting |
NCT04920643 -
High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery
|
N/A | |
Completed |
NCT05934578 -
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
|
N/A | |
Recruiting |
NCT06041685 -
Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
|
N/A | |
Recruiting |
NCT05902013 -
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
|
N/A | |
Not yet recruiting |
NCT05687292 -
Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
|
||
Not yet recruiting |
NCT05524324 -
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
|
N/A | |
Completed |
NCT02746029 -
Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
|
||
Completed |
NCT03119090 -
Fontan Imaging Biomarkers (FIB) Study
|
||
Completed |
NCT02537392 -
Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
|
N/A | |
Recruiting |
NCT02258724 -
Swiss National Registry of Grown up Congenital Heart Disease Patients
|
||
Completed |
NCT01966237 -
Milrinone Pharmacokinetics and Acute Kidney Injury
|
||
Terminated |
NCT02046135 -
Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
|
Phase 2 | |
Recruiting |
NCT01184404 -
Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
|
N/A | |
Completed |
NCT01548950 -
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
|
N/A | |
Completed |
NCT01821287 -
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
|
N/A |